翻訳と辞書 |
Nicosan Nicosan (Hemoxin in US), previously Niprisan or Nix-0699, is a phytochemical (ethanol/water extract of ''Piper guineense'' seeds, ''Pterocarpus osum'' stem, ''Eugenia caryophyllus'' fruit, and ''Sorghum bicolor'' leaves) being tested for the treatment of Sickle-cell disease (SCD). ==Development history== It was developed at the Nigerian National Institute for Pharmaceutical Research and Development (NIPRD) (U.S. Patent # 5,800,819 - September 1, 1998). NIPRD has already conducted Phase I, Phase IIa and IIb clinical trials and is currently conducting Phase III clinical trials in Nigeria. In August 2002, the American company Xechem International with CEO Dr. Ramesh Pandey, acquired the exclusive world-wide rights to Niprisan (later renamed Nicosan/Hemoxin). On July 6, 2006 the drug was officially launched in Nigeria, with the President of Nigeria, Olusegun Obasanjo, in attendance.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Nicosan」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|